Literature DB >> 17544940

Review of non-FDA-approved fillers.

David A F Ellis1, Lorne Segall.   

Abstract

The number of commercially available injectable soft tissue fillers has increased dramatically worldwide over the past decade. In the United States, a variety of temporary non-collagen-based fillers have been approved. However, no permanent soft tissue injectable fillers are currently approved by the US Food and Drug Administration. This article discusses some of the more popular soft tissue fillers, such as Restylane Fine Line, Restylane SQ, Perlane, Artecoll, Dermalive, Dermadeep, Bioalcamid, Bioplastique, Evolution, Outline, Argiform, and Aquamid, which are all available outside of the United States.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17544940     DOI: 10.1016/j.fsc.2007.02.006

Source DB:  PubMed          Journal:  Facial Plast Surg Clin North Am        ISSN: 1064-7406            Impact factor:   1.918


  2 in total

Review 1.  Body shaping and volume restoration: the role of hyaluronic acid.

Authors:  Per Hedén; Gabriella Sellman; Mats von Wachenfeldt; Michael Olenius; Dan Fagrell
Journal:  Aesthetic Plast Surg       Date:  2009-03-12       Impact factor: 2.326

2.  Delayed immune mediated adverse effects to hyaluronic Acid fillers: report of five cases and review of the literature.

Authors:  Ora Bitterman-Deutsch; Leonid Kogan; Faris Nasser
Journal:  Dermatol Reports       Date:  2015-03-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.